Perrigo Fexofenadine Hydrochloride Tablets, 60 mg Drug Facts | Fexofenadine Hydrochloride
Fexofenadine HCl 60 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
if you have ever had an allergic reaction to this product or any of its ingredients.
kidney disease. Your doctor should determine if you need a different dose.
an allergic reaction to this product occurs. Seek medical help right away.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
| adults and children 12 years of age and over | take one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours |
| children under 12 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, titanium dioxide
1-800-719-9260
Compare to Allegra® Allergy active ingredient
Fexofenadine Hydrochloride Tablets, 60 mg
Antihistamine
Non-Drowsy
Relief of:
Sneezing
Runny Nose
Itchy, Watery Eyes
Itchy Nose or Throat
Original Prescription Strength
12 Hour
60 mg Each
Actual Size
Indoor & Outdoor Allergies
Allergy
Manufacturer
Perrigo New York Inc
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Fexofenadine hydrochloride [Prasco Laboratories]
Fexofenadine Hydrochloride Tablets
Fexofenadine hydrochloride [NCS HealthCare of KY, Inc dba Vangard Labs]
Fexofenadine Hydrochloride Tablets
Fexofenadine hydrochloride tablets [BARR LABORATORIES, INC.]
Fexofenadine Hydrochloride Tablets
Fexofenadine hydrochloride and pseudoephedrine hydrochloride [TEVA PHARMACEUTICALS USA INC]
Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets
Fexofenadine hydrochloride and pseudoephedrine hydrochloride [Winthrop U.S.]
Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg Extended-Release Tablets
Clinical Trials
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
This study will compare the relative bioavailability (rate and extent of absorption) of 180 mg Fexofenadine Hydrochloride tablets manufactured for TEVA Pharmaceuticals Industries, Ltd. wit...
Randomized, 2-Way Crossover, Bioequivalence Study of Fexofenadine Hydrochloride 180 mg Tablets of Dr.Reddy's Laboratories Limited, and Allegra® 180 mg Tablets, Aventis Administered as 1 x...
Randomized, 2-Way Crossover, Bioequivalence Study of Fexofenadine Hydrochloride 180 mg Tablets of Dr.Reddy's Laboratories Limited, and Allegra® 180 mg Tablets aventis Administered as...
The primary objective of this study is to determine the efficacy and onsets of action of single-dose fexofenadine hydrochloride 180 mg and montelukast sodium 10 mg relative to placebo. Se...
Examine the relative potency, onset of action and duration of action of fexofenadine HCl 180 mg (Allegra) and montelukast sodium 10 mg (Singulair) as compared to placebo on skin wheals and...
PubMed Articles
Carbamazepine Differentially Affects the Pharmacokinetics of Fexofenadine Enantiomers.
What is already known about this subject- We have shown that P-gp inhibitors such as itraconazole and verapamil significantly increase the plasma concentrations of fexofenadine enantiomers, and their...
Regional absorption of fexofenadine in rat intestine.
Expression of Pgp along the GI-tract of rats increases towards distal segments. We assessed the in vivo relevance by determining the absorption of fexofenadine from proximal and distal parts of rat in...
Pharmacokinetics of fexofenadine following LPS administration to rats.
The function and expression of drug transporters, including P-glycoprotein (P-gp) and organic-anion transporting polypeptides (Oatps), have been investigated but it is not well established how variabl...
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
This study investigated an association of SLCO (encoding organic anion-transporting polypeptides (OATP), 1B1, 1B3, and 2B1), ABCB1 (P-glycoprotein (P-gp)), ABCC2 multidrug resistance protein 2 (MRP2),...
Drug-drug interactions at transporters present a significant and under-investigated clinical problem. Investigations of specific transporter functions and screening for potential drug-drug interaction...
